249 related articles for article (PubMed ID: 18955860)
1. Expression of intestinal and lung alkaline sphingomyelinase and neutral ceramidase in cystic fibrosis f508del transgenic mice.
Ohlsson L; Hjelte L; Hühn M; Scholte BJ; Wilke M; Flodström-Tullberg M; Nilsson A
J Pediatr Gastroenterol Nutr; 2008 Nov; 47(5):547-54. PubMed ID: 18955860
[TBL] [Abstract][Full Text] [Related]
2. Identification of one exon deletion of intestinal alkaline sphingomyelinase in colon cancer HT-29 cells and a differentiation-related expression of the wild-type enzyme in Caco-2 cells.
Wu J; Cheng Y; Nilsson A; Duan RD
Carcinogenesis; 2004 Aug; 25(8):1327-33. PubMed ID: 15016655
[TBL] [Abstract][Full Text] [Related]
3. Small intestinal glucose absorption in cystic fibrosis: a study in human and transgenic DeltaF508 cystic fibrosis mouse tissues.
Hardcastle J; Harwood MD; Taylor CJ
J Pharm Pharmacol; 2004 Mar; 56(3):329-38. PubMed ID: 15025858
[TBL] [Abstract][Full Text] [Related]
4. Psyllium and fat in diets differentially affect the activities and expressions of colonic sphingomyelinases and caspase in mice.
Cheng Y; Ohlsson L; Duan RD
Br J Nutr; 2004 May; 91(5):715-23. PubMed ID: 15137923
[TBL] [Abstract][Full Text] [Related]
5. Effects of bile diversion in rats on intestinal sphingomyelinases and ceramidase.
Duan RD; Verkade HJ; Cheng Y; Havinga R; Nilsson A
Biochim Biophys Acta; 2007 Feb; 1771(2):196-201. PubMed ID: 17204455
[TBL] [Abstract][Full Text] [Related]
6. Alkaline sphingomyelinase activity is decreased in human colorectal carcinoma.
Hertervig E; Nilsson A; Nyberg L; Duan RD
Cancer; 1997 Feb; 79(3):448-53. PubMed ID: 9028353
[TBL] [Abstract][Full Text] [Related]
7. Dietary sphingomyelin inhibits colonic tumorigenesis with an up-regulation of alkaline sphingomyelinase expression in ICR mice.
Zhang P; Li B; Gao S; Duan RD
Anticancer Res; 2008; 28(6A):3631-5. PubMed ID: 19189644
[TBL] [Abstract][Full Text] [Related]
8. Glycoconjugate metabolism in a cystic fibrosis knockout mouse model.
Mailleau C; Paul A; Colin M; Xing PX; Guernier C; Bernaudin JF; Capeau J; Brahimi-Horn MC
Mol Genet Metab; 2001 Feb; 72(2):122-31. PubMed ID: 11161838
[TBL] [Abstract][Full Text] [Related]
9. Human meconium contains significant amounts of alkaline sphingomyelinase, neutral ceramidase, and sphingolipid metabolites.
Duan RD; Cheng Y; Jönsson BA; Ohlsson L; Herbst A; Hellström-Westas L; Nilsson A
Pediatr Res; 2007 Jan; 61(1):61-6. PubMed ID: 17211142
[TBL] [Abstract][Full Text] [Related]
10. Intestinal phenotype of variable-weight cystic fibrosis knockout mice.
Canale-Zambrano JC; Poffenberger MC; Cory SM; Humes DG; Haston CK
Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G222-9. PubMed ID: 17615178
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic trypsin cleaves intestinal alkaline sphingomyelinase from mucosa and enhances the sphingomyelinase activity.
Wu J; Liu F; Nilsson A; Duan RD
Am J Physiol Gastrointest Liver Physiol; 2004 Nov; 287(5):G967-73. PubMed ID: 15205117
[TBL] [Abstract][Full Text] [Related]
12. Altered eicosanoid metabolism in the cystic fibrosis mouse small intestine.
De Lisle RC; Meldi L; Flynn M; Jansson K
J Pediatr Gastroenterol Nutr; 2008 Oct; 47(4):406-16. PubMed ID: 18852632
[TBL] [Abstract][Full Text] [Related]
13. Development of intestinal alkaline sphingomyelinase in rat fetus and newborn rat.
Lillienau J; Cheng Y; Nilsson A; Duan RD
Lipids; 2003 May; 38(5):545-9. PubMed ID: 12880111
[TBL] [Abstract][Full Text] [Related]
14. The F508del mutation in cystic fibrosis transmembrane conductance regulator gene impacts bone formation.
Le Henaff C; Gimenez A; Haÿ E; Marty C; Marie P; Jacquot J
Am J Pathol; 2012 May; 180(5):2068-75. PubMed ID: 22449949
[TBL] [Abstract][Full Text] [Related]
15. Strain-dependent pulmonary gene expression profiles of a cystic fibrosis mouse model.
Haston CK; Cory S; Lafontaine L; Dorion G; Hallett MT
Physiol Genomics; 2006 Apr; 25(2):336-45. PubMed ID: 16614460
[TBL] [Abstract][Full Text] [Related]
16. Carrier frequency of F508del mutation of cystic fibrosis in Indian population.
Kapoor V; Shastri SS; Kabra M; Kabra SK; Ramachandran V; Arora S; Balakrishnan P; Deorari AK; Paul VK
J Cyst Fibros; 2006 Jan; 5(1):43-6. PubMed ID: 16311077
[TBL] [Abstract][Full Text] [Related]
17. Diversity of the basic defect of homozygous CFTR mutation genotypes in humans.
Stanke F; Ballmann M; Bronsveld I; Dörk T; Gallati S; Laabs U; Derichs N; Ritzka M; Posselt HG; Harms HK; Griese M; Blau H; Mastella G; Bijman J; Veeze H; Tümmler B
J Med Genet; 2008 Jan; 45(1):47-54. PubMed ID: 18178635
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic analysis and significance of sphingomyelinase-mediated decreases in transepithelial CFTR currents in nHBEs.
Cottrill KA; Giacalone VD; Margaroli C; Bridges RJ; Koval M; Tirouvanziam R; McCarty NA
Physiol Rep; 2021 Sep; 9(17):e15023. PubMed ID: 34514718
[TBL] [Abstract][Full Text] [Related]
19. Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis.
Teichgräber V; Ulrich M; Endlich N; Riethmüller J; Wilker B; De Oliveira-Munding CC; van Heeckeren AM; Barr ML; von Kürthy G; Schmid KW; Weller M; Tümmler B; Lang F; Grassme H; Döring G; Gulbins E
Nat Med; 2008 Apr; 14(4):382-91. PubMed ID: 18376404
[TBL] [Abstract][Full Text] [Related]
20. Proteasome-dependent pharmacological rescue of cystic fibrosis transmembrane conductance regulator revealed by mutation of glycine 622.
Norez C; Bilan F; Kitzis A; Mettey Y; Becq F
J Pharmacol Exp Ther; 2008 Apr; 325(1):89-99. PubMed ID: 18230692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
